Skip to content

Memory and Picture Viewing Study

Memory and Picture Viewing Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00736203
Acronym
MPVS
Enrollment
116
Registered
2008-08-15
Start date
2008-07-31
Completion date
2011-11-30
Last updated
2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Reactivity of Non-smokers Undergoing fMRI Scanning, Healthy

Keywords

fMRI, non-smokers

Brief summary

The purpose of this study is to obtain a database of brain function from a sample of non-smokers while they do tasks in an MRI (magnetic resonance imaging) machine. Our hypothesis is that among nonsmokers, reactivity to smoking cues will be highly similar to control cues but may vary as a function of attitudes toward smoking and/or family history of smoking. We also hypothesize that brain activity during the n-back task will be more similar to data collected during this task when smokers are not abstinent.

Detailed description

Thirty six non-smokers will undergo functional magnetic resonance imaging (fMRI) scanning. During scanning participants will complete the n-back task-a measure of working memory-and the cue-reactivity task-a measure of responses to smoking cues. Before scanning, participants will complete a training session where they will be familiarized with the tasks. All participants will have to pass a screening visit in order to be included in the study.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* generally healthy * right-handed non-smokers * between the ages of 18-55 * an expired CO concentration of 5 ppm or less; or a negative urine cotinine test of 100 ng/mL or less (to confirm a non-smoker) * having smoked \< 50 cigarettes in their lifetime

Exclusion criteria

* inability to attend all sessions * significant health problems (hypertension, emphysema, seizure disorder, history of significant heart problems) * use of psychoactive medications * use of any tobacco or nicotine containing products * current alcohol or drug abuse * use of illegal drugs as measure by a urine drug screen * presence of conditions that would make MRI unsafe (pacemaker, metallic implants

Design outcomes

Primary

MeasureTime frame
brain reactivity3 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026